AMH Equity’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.88M Buy
660,000
+232,851
+55% +$797K 2.34% 11
2025
Q2
$1.61M Buy
427,149
+174,649
+69% +$687K 2.12% 17
2025
Q1
$1.14M Buy
+252,500
New +$1.34M 1.73% 21

Other funds holding HCAT

AMH Equity's HCAT Position: Q3 2025 in Review

AMH Equity increased its Health Catalyst (HCAT) stake by 55% in Q3 2025, buying an estimated $797K and bringing the position to 660,000 shares worth $1.88M. The position accounts for 2.34% of the portfolio, ranked #11.

AMH Equity first reported a position in HCAT in Q1 2025 and has held it in 3 quarters since. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • AMH Equity held 660,000 shares of Health Catalyst worth $1.88M as of Q3 2025.
  • AMH Equity bought 232,851 Health Catalyst shares in Q3 2025, an estimated $797K.
  • Health Catalyst made up 2.34% of AMH Equity's portfolio in Q3 2025, its #11 holding.
  • AMH Equity first reported a position in Health Catalyst in Q1 2025 and has held it in 3 quarters since.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on AMH Equity's 13F filing for Q3 2025, filed 29 Oct 2025.